Drugmaker to sell cheaper generic rival to EpiPen injectors

A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

Posted: Dec 6, 2018 4:34 PM

TRENTON, N.J. (AP) — A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

The penlike injectors are used to treat life-threatening allergic reactions. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.

Drugmaker Sandoz said Thursday the price of two generic injectors will be $250 without insurance. Two other generics on the market in the U.S. cost $300 a pair. Brand-name EpiPens sold by Mylan cost at least twice as much.

The price people pay varies, though, depending on insurance and discounts.

Mylan was blasted in the past for price hikes that pushed the price over $600. It responded by selling its own generic.

Article Comments

Terre Haute
Broken Clouds
78° wxIcon
Hi: 83° Lo: 44°
Feels Like: 79°
Robinson
Scattered Clouds
53° wxIcon
Hi: 83° Lo: 43°
Feels Like: 53°
Indianapolis
Scattered Clouds
52° wxIcon
Hi: 79° Lo: 44°
Feels Like: 52°
Rockville
Clear
46° wxIcon
Hi: 82° Lo: 42°
Feels Like: 41°
Casey
Scattered Clouds
51° wxIcon
Hi: 80° Lo: 43°
Feels Like: 51°
Brazil
Broken Clouds
78° wxIcon
Hi: 81° Lo: 43°
Feels Like: 79°
Marshall
Broken Clouds
78° wxIcon
Hi: 81° Lo: 43°
Feels Like: 79°
Thunderstorms Possible Tonight
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events